DNLI
Denali Therapeutics Inc Earnings
$18.07
Earnings Summary
Revenue | $0Mn |
Net Profits | $-128.55Mn |
Net Profit Margins | -Inf% |
Denali Therapeutics Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2025. On a quarterly growth basis, Denali Therapeutics Inc has generated NaN% jump in its revenue since last 3-months.
Denali Therapeutics Inc’s net profit fell -12.02% since last year same period to $-128.55Mn in the Q4 2025. On a quarterly growth basis, Denali Therapeutics Inc has generated -1.3% fall in its net profits since last 3-months.
Denali Therapeutics Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2025. On a quarterly growth basis, Denali Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.73 |
EPS Estimate Current Year | -0.73 |
Denali Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.73 - a 2.01% jump from last quarter’s estimates.
Denali Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.73.
Key Ratios
Earning Per Share (EPS) | 0 |
Denali Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Denali Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-12 | -0.73 | 0 | 100% |
